Protagonist Therapeutics PTGX
NASDAQ PTGX
$134.86 -1.40 (-1.03%)
At close: Nov 11, 2026 · 4:00 PM EST

Protagonist Therapeutics (PTGX) Preferred Dividend Payments (2015 - 2016)

Updated

Protagonist Therapeutics' Preferred Dividend Payments was $558,000 in FY2016, up 644.0% from $75,000 in FY2015.

Analysis

Protagonist Therapeutics (PTGX) Preferred Dividend Payments (2015 - 2016) Analysis & Trends

  • Per Business Quant data, Preferred Dividend Payments in earlier years was $75,000 in FY2015 (-48.6%) and $146,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Protagonist Therapeutics 8.89 Bn 6.19 Bn 273.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 293,000.00
Jun 30, 2016 225,000.00
Mar 31, 2016 40,000.00
Dec 31, 2015 39,000.00
API Access

Protagonist Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=PTGX&period=max&api_key=YOUR_API_KEY